Abstract
The World Health Organization defines overweight and obesity as an abnormal or excessive fat accumulation that impairs health. However, there are no well established cut-offs to define obesity based on body fat. The NIH, WHO, the American Association of Clinical Endocrinologist, and the American College of Endocrinology define obesity as an excess of total body fat, specifically body fat that is 20–25% of total body weight in men, and 30–35% in women. But there are not enough data supporting these cut-offs as predictors of adverse outcomes. Furthermore, because direct body fat is difficult to measure, more widely available and easier to perform anthropometric measurements are used in clinical practice. Body mass index is the most commonly used and accepted anthropometric measure to define obesity. It is a well known conditional risk factor for the development of several cardiovascular risk factors, such as diabetes mellitus type 2, metabolic syndrome, systemic hypertension, dyslipidemia, obstructive sleep apnea, etc. However, recently scientists have questioned its usefulness as slightly increased body mass index (overweight and mild obesity range) has been related to improved survival and fewer cardiovascular events when compared to subjects with a normal body mass index, a phenomenon known as the “obesity paradox”. Anthropometric measures of obesity that take into consideration body fat distribution, mainly truncal and/or abdominal obesity, such as waist circumference and specially waist-to-hip ratio appear to better predict cardiovascular risk than BMI alone, but this remains to be proven. Interestingly, despite body fat being the gold standard to define obesity, very little is known regarding its impact as a predictor of all-cause and cardiovascular mortality. The following chapter will analyze the different anthropometric measurements including body fat and lean mass and their impact on mortality with a focus on cardiovascular mortality, the leading cause of death worldwide.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BMI:
-
Body mass index
- CV:
-
Cardiovascular
- HC:
-
Hip circumference
- NIH:
-
The National Institute of Health
- WC:
-
Waist circumference
- WHR:
-
Waist to hip ratio
- WHO:
-
World Health Organization
References
AACE/ACE Obesity Task Force. AACE/ACE position statement on the prevention, diagnosis and treatment of obesity. Endocr Pract. 1998;4:297–450.
Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF. N Engl J Med. 2006;355:763–78.
Allison DB, Zhu SK, Plankey M, Faith MS, Heo M. Int J Obes Relat Metab Disord. 2002;26:410–6.
Barret-Connor E, Khaw KT. Circulation. 1985;72:53–60.
Blew RM, Sardinha LB, Milliken LA, Teixeira PJ, Going SB, Ferreira DL, Harris MM, Houtkooper LB, Lohman TG. Obes Res. 2002;10:799–808.
Calle EE, Thun MJ, Petrelli JM, Rodríguez C, Heath CW Jr. N Engl J Med. 1999;341:1097–105.
CDC. National Health and Nutrition Examination Surveys. National Center for Health Statistics (2003–2004).
CDC. National Center for Health Statistics (2007).
Després JP. Obes Res. 1998;1:8S–17S.
Flegal KM, Graubard BI, Williamson DF, Gail MH JAMA. 2005;293:1861–7.
Flegal KM, Graubard BI, Williamson DF, Gail MH. JAMA. 2007;298:2028–37.
Gill TP Asia Pacific J Clin Nutr. 2001;10:85–89.
Heitmann BL, Frederiksen P, Lissner L. Obes Res. 2004;12:482–7.
Ito H, Nakasuga K, Ohshima A, Maruyama T, Kaji Y, Harada M, Fukunaga M, Jingu S, Sakamoto M. Int J Obesity. 2003;27:232–7.
Krauss RM, Winston M, Fletcher BJ, Grundy SM. Circulation. 1998;98:1472–76.
Lewis CE, McTigue KM, Burke LE, Poirier P, Eckel RH, Howard BV, Allison DB, Kumanyika S, Pi-Sunyer FX. Circulation. 2009;119:3263–71.
McGee DL. Ann Epidemiol. 2005;15:87–97.
National institute of diabetes and digestive and kidney diseases, National Institutes of Health Publication. NIH Publication. 2008;6:3680–I.
Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, van der Schouw YT, Spencer E, Moons KG, Tjønneland A, Halkjaer J, Jensen MK, Stegger J, Clavel-Chapelon F, Boutron-Ruault MC, Chajes V, Linseisen J, Kaaks R, Trichopoulou A, Trichopoulos D, Bamia C, Sieri S, Palli D, Tumino R, Vineis P, Panico S, Peeters PH, May AM, Bueno-de-Mesquita HB, van Duijnhoven FJ, Hallmans G, Weinehall L, Manjer J, Hedblad B, Lund E, Agudo A, Arriola L, Barricarte A, Navarro C, Martinez C, Quirós JR, Key T, Bingham S, Khaw KT, Boffetta P, Jenab M, Ferrari P, Riboli E. N Engl J Med. 2008;359:2105–20.
Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH. Circulation. 2006;113:898–918.
Prospective Studies Collaboration Lancet 2009;373:1083–96.
Rao G. J Fam Pract. 2004;53:53.
Reeder BA, Senthilselvan A, Despres J-P, Angel A, Liu L, Wang H, Rabkin SW Can Med Assoc J. 1997;157:S39–S45.
Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allsion TG, Mookadam F, Lopez-Jimenez F. Lancet. 2006;368:666–78.
Romero-Corral A, Lopez-Jimenez F, Sierra-Johnson J, Somers VK. Nat Clin Pract Endocrinol Metab. 2008;4:322–3.
Romero-Corral A, Somers V, Sierra-Johnson J, Jensen M, Thomas R, Squires R, Allison T, Korniek J, Lopez-Jimenez F. Int J Obes. 2008;28:2087–93.
Schulte H, Cullen P, Assmann G. Atherosclerosis. 1999;144:199–209.
Sharper AG, Wannamethee SG, Walker M. BMJ. 1997;314:1311–7.
Smith SC Jr, Blair SN, Bonow RO, Brass LM, Cerqueira MD, Dracup K, Fuster V, Gotto A, Phil D, Grundy SC, Miller NH, Jacobs A, Jones D, Krauss RM, Mosca L, Ockene I, Pasternak R, Pearson T, Pfeffer MA, Starke RD, Taubert A. J Am Coll Cardiol. 2001;38:1581–83.
Snijder MB, Dekker JM, Visser M, Yudkin JS, Stehouwer CD, Bouter LM, Heine RJ, Nijpels G, Seidell JC. Obes Res. 2003;11:104–11.
Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T. J Am Coll Cardiol. 2008;52:686–717.
Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS, Interheart Study Investigators. Lancet. 2005;366:1640–9.
Western Pacific Regional Office of The World Health Organization, The International Association for the Study of Obesity, The International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia; 2000.
World Health Organization. World Health Report. Geneva: World Health Organization; 2006.
Zeller M, Steg PG, Rivisy J, Lorgis L, Laurent Y, Sicard P, Janin-Manificat L, Beer JC, Makki H, Lagrost AC, Rochette L, Cottin Y. Circulation. 2008;118:482–90.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Mizrahi-Lehrer, E., Cepeda-Valery, B., Romero-Corral, A. (2012). Anthropometry of Body Fat: How Anthropometric Measures Predict Mortality and Especially Cardiovascular Mortality. In: Preedy, V. (eds) Handbook of Anthropometry. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1788-1_21
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1788-1_21
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1787-4
Online ISBN: 978-1-4419-1788-1
eBook Packages: MedicineMedicine (R0)